Additionally, we cannot exclude that at the protein level, NKG2D ligands are downregulated from the cell surface and/or shed as soluble molecules leading to a suboptimal cytolytic activity towards tumor cells and contributing to tumor progression. This evidence concerns the gene KLRK1 and neoplasm.